Get the Stockscreener App
1.653
1.41%
0.023
After Hours:
1.65
-0.003
-0.18%
China Pharma Holdings Inc. Stock (CPHI) Forecast
The China Pharma Holdings Inc. (CPHI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.1486, representing a +90.48% increase from the current price of $1.653. The highest analyst price target is $4.583, and the lowest is $1.7143.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CPHI Price Target
Average 7.6041
(+360.02% Upside)
Is China Pharma Holdings Inc. (CPHI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.81 | Neutral |
| STOCH(9,6) | 8.1999 | Buy |
| STOCHRSI(14) | 11.20 | Buy |
| MACD(12,26) | -0.0761 | Sell |
| ADX(14) | 24.93 | Neutral |
| William %R | -91.04 | Buy |
| CCI(14) | -112.09 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9243
Sell
|
1.8483
Sell
|
| MA20 |
2.0432
Sell
|
1.9359
Sell
|
| MA50 |
1.9715
Sell
|
2.0004
Sell
|
| MA100 |
2.0978
Sell
|
2.0691
Sell
|
| MA200 |
2.1296
Sell
|
2.2845
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CPHI could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CPHI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.81 indicates that CPHI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.1999 indicates that CPHI is oversold. This indicates that CPHI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.2 indicates that CPHI is oversold. This suggests that CPHI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.93 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -112.09 indicates that CPHI is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CPHI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about China Pharma Holdings Inc. financial reports and earnings history, China Pharma Holdings Inc. (CPHI) stock could reach $2.8944 by 2030, $2.1183 by 2040 and $3.1649 by 2050. See the projected annual prices until 2050 of the China Pharma Holdings Inc. stock below:
- China Pharma Holdings Inc. (CPHI) is expected to reach an average price of $0.9596 in 2035, with a high prediction of $1.0158 and a low estimate of $0.969. This indicates an $-41.95% rise from the last recorded price of $1.653.
- China Pharma Holdings Inc. (CPHI) stock is projected to chart a bullish course in 2040, with an average price target of $2.1791, representing an $31.83% surge from its current level. The forecast ranges from a conservative $2.2372 to a sky-high $2.1183.
- Our analysts predict China Pharma Holdings Inc. (CPHI) to jump 98.04% by 2045, soaring from $3.1208 to an average price of $3.2736, potentially reaching $3.057. While $3.1208 is the low estimate, the potential upside is significant.
- China Pharma Holdings Inc. (CPHI) stock is expected to climb by 2050, reaching an average of $2.9171, a $76.47% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.1649 and $3.4774, respectively, highlighting the market's uncertainty.
China Pharma Holdings Inc. Stock (CPHI) Year by Year Forecast
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2025
China Pharma Holdings Inc. Stock (CPHI) is expected to reach an average price of $5.7824 in 2025, with a high prediction of $11.42 and a low estimate of $0.1408. This indicates an +249.81% rise from the last recorded price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $3.558 | $1.7143 | $4.583 | +115.24% |
| August, 2025 | $2.9573 | $2.8503 | $5.2923 | +78.91% |
| September, 2025 | $2.6537 | $2.3484 | $3.704 | +60.54% |
| October, 2025 | $1.2905 | $0.9045 | $3.6661 | -21.93% |
| November, 2025 | $1.3899 | $1.1078 | $1.8859 | -15.92% |
| December, 2025 | $1.6716 | $1.2706 | $3.3793 | +1.13% |
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2026
The predicted value for China Pharma Holdings Inc. (CPHI) in 2026 is set at an average of $7.9008. Estimates vary from a peak of $14.30 to a trough of $1.498, indicating an +377.97% surge from the present price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.549 | $1.498 | $3.806 | +54.21% |
| February, 2026 | $2.1834 | $2.0234 | $3.4447 | +32.09% |
| March, 2026 | $4.6598 | $2.0728 | $6.3708 | +181.90% |
| April, 2026 | $8.8476 | $4.0122 | $11.05 | +435.24% |
| May, 2026 | $8.285 | $5.0463 | $9.9569 | +401.21% |
| June, 2026 | $6.8604 | $5.9943 | $14.30 | +315.03% |
| July, 2026 | $3.9001 | $3.4691 | $7.0217 | +135.94% |
| August, 2026 | $5.1735 | $3.5878 | $9.2972 | +212.98% |
| September, 2026 | $5.1133 | $4.6533 | $6.5822 | +209.33% |
| October, 2026 | $6.8897 | $4.875 | $7.8907 | +316.80% |
| November, 2026 | $5.0861 | $4.9281 | $7.698 | +207.69% |
| December, 2026 | $3.8598 | $3.5078 | $5.3354 | +133.50% |
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for China Pharma Holdings Inc. (CPHI) is $3.4206, with a high forecast of $6.2205 and a low forecast of $0.6207. This indicates an +106.93% increase from the last price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.0752 | $3.2935 | $4.7872 | +146.53% |
| February, 2027 | $4.0486 | $3.9506 | $6.2205 | +144.92% |
| March, 2027 | $2.7073 | $2.4853 | $5.0183 | +63.78% |
| April, 2027 | $2.7737 | $2.2354 | $3.602 | +67.80% |
| May, 2027 | $3.3801 | $1.7074 | $3.7311 | +104.48% |
| June, 2027 | $2.6569 | $2.3992 | $3.6992 | +60.73% |
| July, 2027 | $2.4553 | $1.9426 | $3.3859 | +48.53% |
| August, 2027 | $1.3237 | $1.1317 | $2.6646 | -19.92% |
| September, 2027 | $0.9394 | $0.6207 | $1.6894 | -43.17% |
| October, 2027 | $0.8488 | $0.7768 | $2.8155 | -48.65% |
| November, 2027 | $0.9032 | $0.7832 | $1.1842 | -45.36% |
| December, 2027 | $1.096 | $0.6339 | $1.3516 | -33.70% |
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2028
In 2028, China Pharma Holdings Inc. (CPHI) is projected to reach an average price of $0.7054, with a high projection of $1.4069 and a low estimate of $0.00386. This indicates an -57.33% fall from the last price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6444 | $0.604 | $1.1663 | -61.02% |
| February, 2028 | $0.1358 | $0.1358 | $0.7691 | -91.79% |
| March, 2028 | $0.1335 | $0.0935 | $0.4351 | -91.92% |
| April, 2028 | $0.0251 | $0.00386 | $0.2018 | -98.48% |
| May, 2028 | $0.1331 | $0.0114 | $1.4069 | -91.95% |
| June, 2028 | $0.092 | $0.00404 | $0.2067 | -94.43% |
| July, 2028 | $0.0814 | $0.0276 | $0.1914 | -95.07% |
| August, 2028 | $0.4055 | $0.0192 | $0.2218 | -75.47% |
| September, 2028 | $0.5254 | $0.5025 | $0.4538 | -68.21% |
| October, 2028 | $0.491 | $0.4925 | $0.4068 | -70.30% |
| November, 2028 | $0.4103 | $0.4633 | $0.4683 | -75.18% |
| December, 2028 | $0.4118 | $0.4229 | $0.3939 | -75.09% |
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2029
The 2029 price forecast for China Pharma Holdings Inc. Stock (CPHI) is $1.2252 on average, with a high prediction of $2.4488 and a low estimate of $0.00162. This represents an -25.88% decrease from the previous price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3837 | $0.3851 | $0.3729 | -76.79% |
| February, 2029 | $0.4447 | $0.4547 | $0.4193 | -73.10% |
| March, 2029 | $0.4823 | $0.4954 | $0.4801 | -70.82% |
| April, 2029 | $0.4716 | $0.4733 | $0.4596 | -71.47% |
| May, 2029 | $0.4579 | $0.464 | $0.4575 | -72.30% |
| June, 2029 | $0.3849 | $0.4038 | $0.4318 | -76.72% |
| July, 2029 | $0.3514 | $0.3694 | $0.3762 | -78.74% |
| August, 2029 | $0.3337 | $0.3367 | $0.3438 | -79.82% |
| September, 2029 | $0.3003 | $0.3023 | $0.3193 | -81.84% |
| October, 2029 | $0.0495 | $0.00849 | $0.2895 | -97.01% |
| November, 2029 | $0.0135 | $0.00162 | $0.1078 | -99.18% |
| December, 2029 | $2.7228 | $0.00422 | $2.4488 | +64.72% |
China Pharma Holdings Inc. Stock (CPHI) Price Forecast for 2030
China Pharma Holdings Inc. Stock (CPHI) is expected to reach an average price of $4.4313 in 2030, with a high forecast of $8.848 and a low forecast of $0.0146. This signifies an +168.08% surge from the last price of $1.653.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.1073 | $3.1121 | $2.8944 | +87.98% |
| February, 2030 | $2.9125 | $2.9505 | $2.6625 | +76.20% |
| March, 2030 | $2.9337 | $2.9867 | $2.8077 | +77.48% |
| April, 2030 | $3.0869 | $3.2139 | $2.9533 | +86.75% |
| May, 2030 | $3.1694 | $3.0568 | $3.0554 | +91.74% |
| June, 2030 | $2.8946 | $3.0896 | $3.0877 | +75.11% |
| July, 2030 | $3.1841 | $2.9562 | $2.9511 | +92.63% |
| August, 2030 | $2.9684 | $3.0764 | $2.9137 | +79.57% |
| September, 2030 | $1.9526 | $2.7916 | $2.8427 | +18.12% |
| October, 2030 | $0.5391 | $0.4268 | $4.3242 | -67.39% |
| November, 2030 | $0.3677 | $0.3677 | $8.848 | -77.75% |
| December, 2030 | $0.9555 | $0.0146 | $2.3531 | -42.20% |
3.45%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):